Interestingly, only anti-CD40 agonistic Ab treatment showed a strong anti-tumor effect by activating cytotoxic T cells in a mouse B cell lymphoma transplantation model [39]. Here, CD40 is linked to B-cell non-Hodgkin lymphoma.